StonvexLoading…
StonvexStonvexStonvexCore line items from BTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $614.85M | $573.70M | $688.97M | $646.83M |
Operating Income | $41.21M | $24.21M | $30.47M | $16.52M |
Net Income | $-6.18M | $-11.69M | $-26.10M | $0.00 |
EPS (Diluted) | $-0.86 | $-4.21 | $-1.57 | Not available |
Total Assets | $130.57M | $80.10M | $74.34M | $93.40M |
Total Liabilities | $119.16M | $96.59M | $64.96M | $83.96M |
Cash & Equivalents | $65.63M | $29.47M | $29.76M | $37.54M |
Free Cash Flow OCF − CapEx | $28.49M | $11.79M | $41.08M | $30.14M |
Shares Outstanding | 7.15M | 2.77M | 16.68M | Not available |